nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—SLC22A3—Adefovir Dipivoxil—hepatitis B	0.542	0.63	CbGbCtD
Melphalan—SLC22A3—Lamivudine—hepatitis B	0.317	0.37	CbGbCtD
Melphalan—Muscle atrophy—Lamivudine—hepatitis B	0.00633	0.0449	CcSEcCtD
Melphalan—Foetor hepaticus—Adefovir Dipivoxil—hepatitis B	0.00554	0.0393	CcSEcCtD
Melphalan—Transaminases increased—Entecavir—hepatitis B	0.0053	0.0376	CcSEcCtD
Melphalan—Liver disorder—Adefovir Dipivoxil—hepatitis B	0.00461	0.0327	CcSEcCtD
Melphalan—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.00385	0.0273	CcSEcCtD
Melphalan—Hepatocellular injury—Adefovir Dipivoxil—hepatitis B	0.00314	0.0223	CcSEcCtD
Melphalan—Rhabdomyolysis—Telbivudine—hepatitis B	0.00299	0.0212	CcSEcCtD
Melphalan—Bone marrow depression—Lamivudine—hepatitis B	0.00221	0.0157	CcSEcCtD
Melphalan—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.00217	0.0154	CcSEcCtD
Melphalan—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00211	0.0149	CcSEcCtD
Melphalan—Neutropenia—Entecavir—hepatitis B	0.00189	0.0134	CcSEcCtD
Melphalan—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00171	0.0122	CcSEcCtD
Melphalan—Hepatobiliary disease—Entecavir—hepatitis B	0.00171	0.0121	CcSEcCtD
Melphalan—Rhabdomyolysis—Lamivudine—hepatitis B	0.00169	0.012	CcSEcCtD
Melphalan—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00166	0.0118	CcSEcCtD
Melphalan—Hepatitis—Entecavir—hepatitis B	0.00162	0.0115	CcSEcCtD
Melphalan—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00158	0.0112	CcSEcCtD
Melphalan—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00156	0.0111	CcSEcCtD
Melphalan—Neutropenia—Telbivudine—hepatitis B	0.00155	0.011	CcSEcCtD
Melphalan—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00155	0.011	CcSEcCtD
Melphalan—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00155	0.011	CcSEcCtD
Melphalan—Vasculitis—Lamivudine—hepatitis B	0.00153	0.0108	CcSEcCtD
Melphalan—Immune system disorder—Entecavir—hepatitis B	0.00146	0.0104	CcSEcCtD
Melphalan—Neuropathy peripheral—Telbivudine—hepatitis B	0.00145	0.0103	CcSEcCtD
Melphalan—Alopecia—Entecavir—hepatitis B	0.00143	0.0101	CcSEcCtD
Melphalan—Neuropathy—Lamivudine—hepatitis B	0.0014	0.00993	CcSEcCtD
Melphalan—Hepatobiliary disease—Telbivudine—hepatitis B	0.0014	0.00993	CcSEcCtD
Melphalan—Mouth ulceration—Lamivudine—hepatitis B	0.00135	0.00956	CcSEcCtD
Melphalan—Hepatitis—Telbivudine—hepatitis B	0.00133	0.00942	CcSEcCtD
Melphalan—Connective tissue disorder—Telbivudine—hepatitis B	0.00131	0.00926	CcSEcCtD
Melphalan—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00127	0.00901	CcSEcCtD
Melphalan—Leukopenia—Entecavir—hepatitis B	0.00126	0.00894	CcSEcCtD
Melphalan—Cough—Adefovir Dipivoxil—hepatitis B	0.0012	0.0085	CcSEcCtD
Melphalan—Mediastinal disorder—Telbivudine—hepatitis B	0.0012	0.00849	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00119	0.00844	CcSEcCtD
Melphalan—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00117	0.0083	CcSEcCtD
Melphalan—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00117	0.0083	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00116	0.00824	CcSEcCtD
Melphalan—Anaphylactic shock—Entecavir—hepatitis B	0.00115	0.00815	CcSEcCtD
Melphalan—Infection—Entecavir—hepatitis B	0.00114	0.0081	CcSEcCtD
Melphalan—Skin disorder—Entecavir—hepatitis B	0.00112	0.00792	CcSEcCtD
Melphalan—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.0011	0.00779	CcSEcCtD
Melphalan—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00109	0.00772	CcSEcCtD
Melphalan—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00107	0.00758	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00102	0.00725	CcSEcCtD
Melphalan—Dyspepsia—Entecavir—hepatitis B	0.00101	0.00717	CcSEcCtD
Melphalan—Cough—Telbivudine—hepatitis B	0.00101	0.00716	CcSEcCtD
Melphalan—Liver function test abnormal—Lamivudine—hepatitis B	0.001	0.00709	CcSEcCtD
Melphalan—Gastrointestinal disorder—Entecavir—hepatitis B	0.000993	0.00704	CcSEcCtD
Melphalan—Fatigue—Entecavir—hepatitis B	0.000991	0.00703	CcSEcCtD
Melphalan—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.000987	0.007	CcSEcCtD
Melphalan—Chest pain—Telbivudine—hepatitis B	0.000985	0.00698	CcSEcCtD
Melphalan—Myalgia—Telbivudine—hepatitis B	0.000985	0.00698	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.000979	0.00694	CcSEcCtD
Melphalan—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.000975	0.00691	CcSEcCtD
Melphalan—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.000969	0.00687	CcSEcCtD
Melphalan—Thrombocytopenia—Telbivudine—hepatitis B	0.000925	0.00656	CcSEcCtD
Melphalan—Skin disorder—Telbivudine—hepatitis B	0.000917	0.0065	CcSEcCtD
Melphalan—Pancytopenia—Lamivudine—hepatitis B	0.000889	0.0063	CcSEcCtD
Melphalan—Neutropenia—Lamivudine—hepatitis B	0.000875	0.0062	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.000861	0.0061	CcSEcCtD
Melphalan—Paraesthesia—Telbivudine—hepatitis B	0.000848	0.00601	CcSEcCtD
Melphalan—Dyspepsia—Telbivudine—hepatitis B	0.000831	0.00589	CcSEcCtD
Melphalan—Asthenia—Entecavir—hepatitis B	0.000825	0.00585	CcSEcCtD
Melphalan—Neuropathy peripheral—Lamivudine—hepatitis B	0.000818	0.0058	CcSEcCtD
Melphalan—Gastrointestinal disorder—Telbivudine—hepatitis B	0.000815	0.00578	CcSEcCtD
Melphalan—Fatigue—Telbivudine—hepatitis B	0.000814	0.00577	CcSEcCtD
Melphalan—Stomatitis—Lamivudine—hepatitis B	0.000814	0.00577	CcSEcCtD
Melphalan—Jaundice—Lamivudine—hepatitis B	0.000814	0.00577	CcSEcCtD
Melphalan—Pain—Telbivudine—hepatitis B	0.000808	0.00573	CcSEcCtD
Melphalan—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000805	0.00571	CcSEcCtD
Melphalan—Pruritus—Adefovir Dipivoxil—hepatitis B	0.000794	0.00563	CcSEcCtD
Melphalan—Hepatobiliary disease—Lamivudine—hepatitis B	0.000789	0.0056	CcSEcCtD
Melphalan—Diarrhoea—Entecavir—hepatitis B	0.000787	0.00558	CcSEcCtD
Melphalan—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000768	0.00544	CcSEcCtD
Melphalan—Hepatitis—Lamivudine—hepatitis B	0.000749	0.00531	CcSEcCtD
Melphalan—Connective tissue disorder—Lamivudine—hepatitis B	0.000736	0.00522	CcSEcCtD
Melphalan—Vomiting—Entecavir—hepatitis B	0.000731	0.00518	CcSEcCtD
Melphalan—Rash—Entecavir—hepatitis B	0.000725	0.00514	CcSEcCtD
Melphalan—Dermatitis—Entecavir—hepatitis B	0.000724	0.00513	CcSEcCtD
Melphalan—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000713	0.00506	CcSEcCtD
Melphalan—Rash—Adefovir Dipivoxil—hepatitis B	0.000707	0.00501	CcSEcCtD
Melphalan—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000707	0.00501	CcSEcCtD
Melphalan—Nausea—Entecavir—hepatitis B	0.000683	0.00484	CcSEcCtD
Melphalan—Asthenia—Telbivudine—hepatitis B	0.000678	0.0048	CcSEcCtD
Melphalan—Immune system disorder—Lamivudine—hepatitis B	0.000677	0.0048	CcSEcCtD
Melphalan—Mediastinal disorder—Lamivudine—hepatitis B	0.000675	0.00479	CcSEcCtD
Melphalan—Pruritus—Telbivudine—hepatitis B	0.000668	0.00474	CcSEcCtD
Melphalan—Nausea—Adefovir Dipivoxil—hepatitis B	0.000666	0.00472	CcSEcCtD
Melphalan—Alopecia—Lamivudine—hepatitis B	0.000662	0.00469	CcSEcCtD
Melphalan—Diarrhoea—Telbivudine—hepatitis B	0.000646	0.00458	CcSEcCtD
Melphalan—Anaemia—Lamivudine—hepatitis B	0.000603	0.00427	CcSEcCtD
Melphalan—Vomiting—Telbivudine—hepatitis B	0.000601	0.00426	CcSEcCtD
Melphalan—Rash—Telbivudine—hepatitis B	0.000596	0.00422	CcSEcCtD
Melphalan—Dermatitis—Telbivudine—hepatitis B	0.000595	0.00422	CcSEcCtD
Melphalan—Leukopenia—Lamivudine—hepatitis B	0.000584	0.00414	CcSEcCtD
Melphalan—Cough—Lamivudine—hepatitis B	0.000569	0.00403	CcSEcCtD
Melphalan—Convulsion—Lamivudine—hepatitis B	0.000565	0.00401	CcSEcCtD
Melphalan—Nausea—Telbivudine—hepatitis B	0.000561	0.00398	CcSEcCtD
Melphalan—Chest pain—Lamivudine—hepatitis B	0.000555	0.00394	CcSEcCtD
Melphalan—Myalgia—Lamivudine—hepatitis B	0.000555	0.00394	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000551	0.00391	CcSEcCtD
Melphalan—Anaphylactic shock—Lamivudine—hepatitis B	0.000532	0.00377	CcSEcCtD
Melphalan—Oedema—Lamivudine—hepatitis B	0.000532	0.00377	CcSEcCtD
Melphalan—Infection—Lamivudine—hepatitis B	0.000529	0.00375	CcSEcCtD
Melphalan—Thrombocytopenia—Lamivudine—hepatitis B	0.000521	0.00369	CcSEcCtD
Melphalan—Skin disorder—Lamivudine—hepatitis B	0.000517	0.00367	CcSEcCtD
Melphalan—Anorexia—Lamivudine—hepatitis B	0.000507	0.0036	CcSEcCtD
Melphalan—Hypotension—Lamivudine—hepatitis B	0.000497	0.00353	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000485	0.00344	CcSEcCtD
Melphalan—Paraesthesia—Lamivudine—hepatitis B	0.000478	0.00339	CcSEcCtD
Melphalan—Dyspnoea—Lamivudine—hepatitis B	0.000475	0.00336	CcSEcCtD
Melphalan—Dyspepsia—Lamivudine—hepatitis B	0.000469	0.00332	CcSEcCtD
Melphalan—Decreased appetite—Lamivudine—hepatitis B	0.000463	0.00328	CcSEcCtD
Melphalan—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00046	0.00326	CcSEcCtD
Melphalan—Fatigue—Lamivudine—hepatitis B	0.000459	0.00325	CcSEcCtD
Melphalan—Pain—Lamivudine—hepatitis B	0.000455	0.00323	CcSEcCtD
Melphalan—Urticaria—Lamivudine—hepatitis B	0.000423	0.003	CcSEcCtD
Melphalan—Hypersensitivity—Lamivudine—hepatitis B	0.000392	0.00278	CcSEcCtD
Melphalan—Asthenia—Lamivudine—hepatitis B	0.000382	0.00271	CcSEcCtD
Melphalan—Pruritus—Lamivudine—hepatitis B	0.000377	0.00267	CcSEcCtD
Melphalan—Diarrhoea—Lamivudine—hepatitis B	0.000364	0.00258	CcSEcCtD
Melphalan—Vomiting—Lamivudine—hepatitis B	0.000338	0.0024	CcSEcCtD
Melphalan—Rash—Lamivudine—hepatitis B	0.000336	0.00238	CcSEcCtD
Melphalan—Dermatitis—Lamivudine—hepatitis B	0.000335	0.00238	CcSEcCtD
Melphalan—Nausea—Lamivudine—hepatitis B	0.000316	0.00224	CcSEcCtD
